ECG
TMO icon

Edge Capital Group’s Thermo Fisher Scientific TMO Stock Holding History

Edge Capital Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$1.49M Buy
2,862
+197
+7% +$108K 0.07% 144
2024
Q3 		$1.65M Sell
2,665
-38
-1% -$22.5K 0.07% 133
2024
Q2 		$1.49M Hold
2,703
– – 0.07% 138
2024
Q1 		$1.57M Buy
2,703
+113
+4% +$63.4K 0.08% 134
2023
Q4 		$1.37M Buy
2,590
+122
+5% +$59.1K 0.08% 143
2023
Q3 		$1.25M Hold
2,468
– – 0.08% 140
2023
Q2 		$1.29M Sell
2,468
-134
-5% -$72.3K 0.07% 158
2023
Q1 		$1.5M Sell
2,602
-1,364
-34% -$769K 0.09% 143
2022
Q4 		$2.18M Buy
3,966
+862
+28% +$457K 0.15% 103
2022
Q3 		$1.57M Sell
3,104
-11
-0.4% -$6.16K 0.13% 108
2022
Q2 		$1.69M Buy
3,115
+44
+1% +$24.2K 0.15% 111
2022
Q1 		$1.81M Sell
3,071
-114
-4% -$65.5K 0.12% 111
2021
Q4 		$2.13M Sell
3,185
-29
-0.9% -$18.1K 0.15% 104
2021
Q3 		$1.84M Sell
3,214
-101
-3% -$55.4K 0.15% 106
2021
Q2 		$1.67M Sell
3,315
-29
-0.9% -$13.7K 0.13% 110
2021
Q1 		$1.53M Sell
3,344
-200
-6% -$95.5K 0.13% 107
2020
Q4 		$1.65M Buy
3,544
+59
+2% +$27.7K 0.14% 106
2020
Q3 		$1.54M Sell
3,485
-175
-5% -$72.3K 0.15% 102
2020
Q2 		$1.33M Buy
3,660
+60
+2% +$20.1K 0.14% 105
2020
Q1 		$1.02M Sell
3,600
-48
-1% -$15.1K 0.12% 110
2019
Q4 		$1.19M Hold
3,648
– – 0.12% 111
2019
Q3 		$1.06M Sell
3,648
-413
-10% -$118K 0.11% 114
2019
Q2 		$1.19M Buy
4,061
+466
+13% +$128K 0.11% 113
2019
Q1 		$984K Sell
3,595
-330
-8% -$82.1K 0.1% 121
2018
Q4 		$878K Buy
+3,925
New +$921K 0.1% 113

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Edge Capital Group's TMO Position: Q4 2024 in Review

Edge Capital Group increased its Thermo Fisher Scientific (TMO) stake by 7.4% in Q4 2024, buying an estimated $108K and bringing the position to 2,862 shares worth $1.49M. The position accounts for 0.07% of the portfolio, ranked #144.

Edge Capital Group first reported a position in TMO in Q4 2018 and has held it in 25 quarters since. The position peaked at $2.18M in Q4 2022. 2,616 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Edge Capital Group held 2,862 shares of Thermo Fisher Scientific worth $1.49M as of Q4 2024.
  • Edge Capital Group bought 197 Thermo Fisher Scientific shares in Q4 2024, an estimated $108K.
  • Thermo Fisher Scientific made up 0.07% of Edge Capital Group's portfolio in Q4 2024, its #144 holding.
  • Edge Capital Group first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 25 quarters since.
  • Edge Capital Group's Thermo Fisher Scientific position peaked at $2.18M in Q4 2022.
  • 2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Edge Capital Group's 13F filing for Q4 2024, filed 4 Feb 2025.